IFNA1 and COVID-19: Since aberrant IFN and cytokine responses were observed in COVID-19 patients (Moore and June, 2020) and ADAR1 was shown to activate the IFN reaction (Baños-Lara et al., 2013), we further interrogate the activity of A-to-I RNA editing upon SARS-CoV-2 infection.